697 related articles for article (PubMed ID: 28301050)
1. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
Chauhan BF; Jeyaraman MM; Singh Mann A; Lys J; Abou-Setta AM; Zarychanski R; Ducharme FM
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010347. PubMed ID: 28301050
[TBL] [Abstract][Full Text] [Related]
2. Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma.
Chauhan BF; Ben Salah R; Ducharme FM
Cochrane Database Syst Rev; 2013 Oct; (10):CD009585. PubMed ID: 24089325
[TBL] [Abstract][Full Text] [Related]
3. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
[TBL] [Abstract][Full Text] [Related]
4. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
[TBL] [Abstract][Full Text] [Related]
5. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
6. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
Anderson DE; Kew KM; Boyter AC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
[TBL] [Abstract][Full Text] [Related]
7. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ram FS; Cates CJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
[TBL] [Abstract][Full Text] [Related]
8. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
9. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
[TBL] [Abstract][Full Text] [Related]
10. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
Chauhan BF; Ducharme FM
Cochrane Database Syst Rev; 2012 May; 2012(5):CD002314. PubMed ID: 22592685
[TBL] [Abstract][Full Text] [Related]
11. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
[TBL] [Abstract][Full Text] [Related]
12. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.
Chong J; Haran C; Chauhan BF; Asher I
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD011032. PubMed ID: 26197430
[TBL] [Abstract][Full Text] [Related]
13. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
[TBL] [Abstract][Full Text] [Related]
14. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.
Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
Cochrane Database Syst Rev; 2010 Apr; (4):CD005533. PubMed ID: 20393943
[TBL] [Abstract][Full Text] [Related]
15. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
16. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005307. PubMed ID: 19821344
[TBL] [Abstract][Full Text] [Related]
17. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.
Ahmad S; Kew KM; Normansell R
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011306. PubMed ID: 26089258
[TBL] [Abstract][Full Text] [Related]
18. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
Kew KM; Quinn M; Quon BS; Ducharme FM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007524. PubMed ID: 27272563
[TBL] [Abstract][Full Text] [Related]
19. Addition of antileukotriene agents to inhaled corticosteroids in children with persistent asthma.
Chong JK; Chauhan BF
Paediatr Child Health; 2014 Nov; 19(9):473-4. PubMed ID: 25414582
[TBL] [Abstract][Full Text] [Related]
20. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma.
Kew KM; Dahri K
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
